Bacterial The product of gene N of bacteriophage X is a positive regulator of phage development (1). It regulates by stimulating transcription of the cII-O-P and cIIl-exo operons. Surprisingly, it does not act at the right (pr) or left (pl) promoters that initiate these operons, but at sites distal to them (1-4). Genetic and biochemical experiments (1, 5, 6) suggest three major sites of N-product action on X DNA: one between genes N and cldI, one between genes cro and 0, and one between genes P and Q (Fig. 1) . Roberts (7) has proposed that the termination factor for RNA synthesis, p, terminates transcription at these sites. In some way the N product permits transcription beyond the three termination sites. Three kinds of explanation for this action can be proposed: (a) N product is a new RNA polymerase; (b) N product modifies the specificity of the host RNA polymerase; (c) N-gene product is, or modifies, a component of the transcription system other than RNA polymerase, for example, the p factor.
The product of gene N of bacteriophage X is a positive regulator of phage development (1) . It regulates by stimulating transcription of the cII-O-P and cIIl-exo operons. Surprisingly, it does not act at the right (pr) or left (pl) promoters that initiate these operons, but at sites distal to them (1) (2) (3) (4) . Genetic and biochemical experiments (1, 5, 6) suggest three major sites of N-product action on X DNA: one between genes N and cldI, one between genes cro and 0, and one between genes P and Q (Fig. 1) . Roberts (7) has proposed that the termination factor for RNA synthesis, p, terminates transcription at these sites. In some way the N product permits transcription beyond the three termination sites. Three kinds of explanation for this action can be proposed: (a) N product is a new RNA polymerase; (b) N product modifies the specificity of the host RNA polymerase; (c) N-gene product is, or modifies, a component of the transcription system other than RNA polymerase, for example, the p factor.
In a class of bacterial mutants called groN, X growth is arrested because the N-gene product fails to function (8) . The properties of groN strains, and of the RNA polymerase isolated from them, show that the groN mutation causes a structural change in the bacterial RNA polymerase. Since this mutation prevents the action of the N product, it suggests that the N product works through the host polymerase.
MATERIALS AND METHODS
Bacterial mutants were isolated from SKB178, a galE-, su-X-sensitive prototroph of Escherichia coli K12. Strain WGS6 (9) contains a defective X prophage, in which phage genes both to the right of the immunity region and to the left of the immunity region, starting with cldI, are deleted. SA462 carries a different defective X prophage, in which phage genes beginning in P and extending to the right are deleted. SA268 contains a defective X prophage, in which Q and genes to the right are deleted. SA268 and SA462 were isolated by Sankar Adhya and were obtained from D. Court. Phage Xtrp46N+fed and Xtrp48N+fed [the fed mutation blocks the early turn-off of the clII-exo operon, and appears to be identical to cro (10) Rifamycin-resistant bacterial mutants were isolated as follows: 1010 SKB178 cells, grown in TYM-broth, were spread on TYM-agar plates containing 50,ug/ml of rifamycin (Rifampin, Calbiochem). Rifamycin-resistant colonies appeared after 18 hr of incubation at 37-0C.
Plvir phage stocks were prepared and used to transduce the rifamycin-resistance marker as described by Scott (15) .
RESULTS

Phage growth in groN strains
Bacterial mutants have been isolated that block X development at stages after adsorption and injection. These The trp genes of E. coli can be incorporated into X DNA in such a way that expression of these genes is entirely dependent upon transcription from pl (6) . In ?trp46, synthesis of the tryptophan biosynthetic enzymes requires an active Ngene product. Thus, fusion occurred to the left of the termination signal between N and cIII, and the amount of trp enzymes produced after infection by such a phage measures Ngene function (6) . Other strains, such as Xtrp48, express the trp enzymes in the absence of the N function, because the trp operon is fused to X with loss of the mRNA-termination signal between N and ciii (6) . The amount of trp enzymes produced after infection by Xtrp48 is, therefore, a measure of the total transcription initiated at pl.
In groN785, the N-dependent Xtrp46 fails to synthesize Component II of the anthranilate synthetase complex, the product of the trpD gene (Fig. 2) . The rate of enzyme formation was more than 1000-fold lower in groN785 than in its gro+ parent. In groN785, the N-independent Xtrp48 synthesized Component II of the anthranilate synthetase complex at a rate comparable to that found in gro+ (Fig. 2) . These results imply that in groN785, transcription is initiated normally at pl and, therefore, that the N gene itself is transcribed. Nevertheless, transcription beyond the N-cIII termination signal fails to occur in groN785.
Phage mutants that can multiply on groN bacteria At least two classes of phage mutant might be expected to grow on groN bacteria: (a) phage that have lost the requirement for the N product, and (b) phage that synthesize an N product suitably modified to compensate for the alteration in groN bacteria. Both classes have been found.
One kind of N-independent mutant of X, called nin (18) , has been isolated from X N -mutants. Xnin have lost a segment of DNA between genes P and Q (19) and, as expected, they plate on groN bacteria (Table 1) . Phage mutants called v have also been isolated from Ximm4" and 434 by their ability to grow on groN strains (Table 1) . One class of v mutants, called vB, is located (9/9 tested) between genes P and Q, defined by the end points of the SA268 and SA462 deletions. Thus, vB resembles nin.
The rest of the v mutants, called 'A (Table 1) , map in or near the N gene, as shown by the following experiments. PA lies outside the immunity region, since it can be crossed from Ximm4"4 into X and vice versa. A PA + allele can be extracted from the deletion prophage in bacterial strain WGS6 or from a cross with XbiolO. Lambda biolO is deleted from the right side of the prophage attachment site through cIII (20) . Therefore, vA must be located to the right of clII and to the left of the immunity region. 12 crosses, each with a different vA mutation, of the type imm484susN7 X immXvA, yielded a minority (5-30%) of the imm434N+ recombinants as PA, indicating that these vA mutations map to the right of N7. With five other vA mutations in similar crosses, 65-95% of the imm434N+ recombinants were vA, suggesting a closer linkage between N7 and these 'A mutations.
One of the vA mutants, vA 16, though it can multiply on groN bacteria, is unable to multiply on gro+ bacteria. The defect of vA16 in gro+ bacteria can be complemented by N+ SU029 or by N + susP8o, but not by susN7N53 0 + P+ phage. chains, more specific initiations, and an increase in the rate of chain growth (22) . The response of gro+ and groN RNA polymerases to a range of KCl concentrations are compared in Fig. 3 . The gro+ RNA polymerase activity on T4 DNA was stimulated more than 10-fold by the addition of 0.2 M KCl. GroN polymerase was stimulated less than the gro+ enzyme at all the KCl concentrations tested, and was stimulated only 4-fold at 0.2 M KCl.
E. coli RNA polymerase is sensitive, both in vivo and in vitro, to the antibiotic rifamycin (23) . Rifamycin inhibits the enzyme by interaction with the ,B subunit of core polymerase, as shown by (a) the binding of radioactive rifamycin to purified subunit, but not to the a or fl' subunits (24) and (b) the fact that a rifamycin-resistant mutant possesses an electrophoretically altered , subunit (21) . The exact stage of RNA synthesis at which rifamycin exerts its inhibitory effect is not known. It does not seem to inhibit RNA polymerase during chain propagation, to prevent the formation of a stable enzyme-DNA complex, or to cause its release from DNA. Goldthwait et al. (25) have suggested that rifamycin blocks the formation of an initiation complex of the enzyme with a purine ribonucleoside triphosphate.
The purified polymerases were tested for their relative sensitivity in vitro to various amounts of rifamycin. Very little, if any, difference in sensitivity to rifamycin was found between the gro+ and groN RNA polymerases, with calf-thymus DNA as a template, in the absence of added salt (Fig. 4a) . With T4 DNA as a template, in the absence of added salt, the groN RNA polymerase activity was more sensitive to rifamycin than was its gro+ counterpart (Fig. 4a) . A differential response to rifamycin was most clearly noted in the presence of 0.03 M or higher concentrations of (NH4)2S04. The gro+ polymerase was relatively insensitive to low concentrations of rifamycin with calf-thymus and T4 DNA. However, the ammonium sulfate concentration had no effect on the sensitivity of the groN polymerase to rifamycin (Fig. 4b) .
A preliminary experiment with phosphocellulose-treated enzyme (17) , with calf-thymus DNA as template, suggested that this enhanced sensitivity of the groN RNA polymerase to rifamycin is a property of the core enzyme (enzyme without a factor).
CONCLUSIONS
The properties of groN help to discriminate among the three ways N product might act: (a) The N gene might code for a viral RNA polymerase analogous to the gene 1 product of bacteriophages T7 and T3 (26, 27) . This new enzyme would be able to initiate transcription past the termination signals. (b) The N product might modify bacterial RNA polymerase by combining with it, or by replacing or modifying one of its subunits, as observed in the case of bacteriophage T4 (28) and during bacterial sporulation (29) . The interaction of RNA polymerase and N product might result either in a failure to read or obey the mRNA termination signals, or in an ability to initiate mRNA transcription at promoter sites beyond the termination signals. (c) Finally, N product might act by modifying a component of the transcription system other than polymerase, for example, the p factor.
The evidence described here shows that the groN phenotype results from change in the bacterial RNA polymerase. Thus, models (a) and (c) are probably not correct. Rather, it appears that the N-gene product of X interacts with bacterial RNA polymerase to change its specificity so that it can transcribe fully the cII--P and cIll-exo operons.
The rarity of groN mutants may be explained by the constraints placed on the structure of the mutant enzyme, which must still be able to read bacterial transcription signals properly.
